SEARCH

SEARCH BY CITATION

References

  • 1
    Rangachari PK. Histamine: mercurial messenger in the gut. Am J Physiol 1992;262(1 Pt 1):G1G13.
  • 2
    Takagi T, Takeda M, Maeno H. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpro pionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. Arch Int Pharmacodyn Ther 1982;256:4958.
  • 3
    Lampiasi N, Azzolina A, Montalto G, Cervello M. Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Exp Mol Med 2007;39:284294.
  • 4
    Mamune-Sato R, Yamauchi K, Tanno Y, Ohkawara Y, Ohtsu H, Katayose D et al. Functional analysis of alternatively spliced transcripts of the human histidine decarboxylase gene and its expression in human tissues and basophilic leukemia cells. Eur J Biochem 1992;209:533539.
  • 5
    Garcia-Martin E, Ayuso P, Martinez C, Blanca M, Agundez JA. Histamine pharmacogenomics. Pharmacogenomics 2009;10:867883.
  • 6
    Yan L, Galinsky RE, Bernstein JA, Liggett SB, Weinshilboum RM. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics 2000;10:261266.
  • 7
    Garcia-Martin E, Garcia-Menaya J, Sanchez B, Martinez C, Rosendo R, Agundez JA. Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis. Clin Exp Allergy 2007;37:11751182.
  • 8
    Hirata N, Takeuchi K, Ukai K, Sakakura Y. Expression of histidine decarboxylase messenger RNA and histamine N-methyltransferase messenger RNA in nasal allergy. Clin Exp Allergy 1999;29:7683.
  • 9
    Wood-Baker R, Finnerty JP, Holgate ST. Plasma and urinary histamine in allergen-induced early and late phase asthmatic responses. Eur Respir J 1993;6:11381144.
  • 10
    Kopriva F, Szotkowska J, Plocova A, Zavodska J, Zapalka M, Smatanova D et al. The use of oscillometry as a measure of airway responsiveness in asthmatic children after histamine and methacholine bronchoprovocation with dosimeter-MedicAid and DeVilbiss nebulizers. J Asthma 2007;44:267271.
  • 11
    Purokivi M, Koskela HO, Koistinen T, Magga J, Peuhkurinen K, Kiviniemi V et al. Utility of cough response during hypertonic histamine challenge in diagnosing asthma. Respir Med 2008;102:13791384.
  • 12
    Wuestenberg EG, Hauswald B, Huettenbrink KB. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers. Am J Rhinol 2004;18:371375.
  • 13
    Bachert C. Histamine--a major role in allergy? Clin Exp Allergy 1998;28(Suppl 6):1519.
  • 14
    Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81(5 Pt 2):478518.
  • 15
    Dreborg S. Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen. Allergy 1993;48:473475.
  • 16
    American_Thoracic_Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225244.
  • 17
    Global_Initiative_for_Asthma. Global strategy for asthma management and prevention: NHLBI/WHO workshop report; updated 2004. Bethesda (MD): National Institutes of Health, National Heart, Lung and Blood Institute; 2004. Publication no. 02-3659.
  • 18
    Garcia-Martin E, Martinez C, Pizarro RM, Garcia-Gamito FJ, Gullsten H, Raunio H et al. CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity. Clin Pharmacol Ther 2002;71:196204.
  • 19
    Pértega Diaz S, Pita Fernández S. Cálculo del poder estadístico de un estudio. Cuad Aten Prim 2003;10:5963.
  • 20
    Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002;23:381387.
  • 21
    Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 2005;1:4750.
  • 22
    Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978989.
  • 23
    Agundez JA, Golka K, Martinez C, Selinski S, Blaszkewicz M, Garcia-Martin E. Unraveling ambiguous NAT2 genotyping data. Clin Chem 2008;54:13901394.
  • 24
    Moya-Garcia AA, Pino-Angeles A, Gil-Redondo R, Morreale A, Sanchez-Jimenez F. Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition. Br J Pharmacol 2009;157:413.
  • 25
    Ayuso P, Garcia-Martin E, Martinez C, Agundez JA. Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity. Pharmacogenet Genomics 2007;17:687693.
  • 26
    Garcia-Martin E, Ayuso P, Martinez C, Agundez JA. Improved analytical sensitivity reveals the occurrence of gender-related variability in diamine oxidase enzyme activity in healthy individuals. Clin Biochem 2007;40:13391341.
  • 27
    Garcia-Martin E, Mendoza JL, Martinez C, Taxonera C, Urcelay E, Ladero JM et al. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J Gastroenterol 2006;12:615620.
  • 28
    Kennedy MJ, Loehle JA, Griffin AR, Doll MA, Kearns GL, Sullivan JE et al. Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children. Pharmacotherapy 2008;28:14951501.